Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

ARAY stock hub

Accuray Incorporated has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ARAYis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

45.2M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

ARAY

In the news

Latest news · ARAY

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-101.1

P25 -105.6P50 -46.5P75 -3.1

ROIC-6.6

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ARAY market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

216

Groups with data

Currency

USD

Showing 216 of 216 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001138723
Company name	Accuray Incorporated
Country	United States
Country code	US
Cusip	004397105
Employees	990
Employees Change	3%
Employees Change Percent	0.3
Enterprise value	$189.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2007-02-08
Isin	US0043971052
Last refreshed	2026-05-10
Market cap	$45.2M
Market cap category	Nano-Cap
Price	$0.38
Price currency	USD
Rev Per Employee	432,900x
Sector	Healthcare
Sic	3841
Symbol	ARAY
Website	https://www.accuray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-102.04%
EV Sales Forward	0.4x
EV/Sales	0.44x
FCF yield	-57.15%
P/B ratio	1.08x
P/S ratio	0.11x
PS Forward	0.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-2.87%
EBITDA Margin	-1.3%
Gross margin	26.92%
Gross Profit	$115.4M
Gross Profit Growth	-21.23%
Gross Profit Growth Q	-20.02%
Gross Profit Growth3 Y	-10.2%
Gross Profit Growth5 Y	-5.8%
Net Income	$-46.1M
Net Income Growth Years	1%
Pretax Margin	-10.19%
Profit Margin	-10.76%
Profit Per Employee	$-46,596
ROA	-1.65
Roa5y	1.14
ROCE	-5.09
ROE	-101.1
Roe5y	-13.93
ROIC	-6.61
Roic5y	3.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-22.83%
Cagr15y	-18.37%
Cagr1y	-72.08%
Cagr3y	-52.47%
Cagr5y	-39.89%
EPS Growth Years	1
Revenue Growth	-7.88x
Revenue Growth Q	-7.42x
Revenue Growth Years	1x
Revenue Growth3 Y	-0.82x
Revenue Growth5 Y	2.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.92
Assets	$447.6M
Cash	$38.1M
Current Assets	$293.2M
Current Liabilities	$205.8M
Debt	$182.4M
Debt EBITDA	$46.18
Debt Equity	$4.37
Equity	$41.7M
Interest Coverage	-0.43
Liabilities	$405.9M
Long Term Assets	$154.4M
Long Term Liabilities	$200.1M
Net Cash	$-144.3M
Net Cash By Market Cap	$-319
Net Debt Equity	$3.46
Tangible Book Value	$-16.2M
Tangible Book Value Per Share	$-0.14
WACC	12.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.42
Inventory Turnover	2.07
Net Working Capital	$68.7M
Quick ratio	0.58
Working Capital	$87.4M
Working Capital Turnover	$3.94

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.56%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-92.5%
1Y total return	-72.06%
200-day SMA	1.01
3Y total return	-89.27%
50-day SMA	0.43
50-day SMA vs 200-day SMA	50under200
5Y total return	-92.15%
All Time High	31.09
All Time High Change	-98.78%
All Time High Date	2007-02-09
All Time Low	0.28
All Time Low Change	35.67%
All Time Low Date	2026-05-07
ATR	0.06
Beta	1.43
Beta1y	1.62
Beta2y	1.87
Ch YTD	-53.92
High	0.38
High52	2.1
High52 Date	2025-10-10
High52ch	-81.9%
Low	0.3
Low52	0.28
Low52 Date	2026-05-07
Low52ch	35.67%
Ma50ch	-11.96%
Premarket Change Percent	3.65
Premarket Price	$0.3
Premarket Volume	92,109
Price vs 200-day SMA	-62.34%
RSI	44.4
RSI Monthly	29.11
RSI Weekly	27.03
Sharpe ratio	-0.96x
Sortino ratio	-1.24
Total Return	-16.56%
Tr YTD	-53.92
Tr15y	-95.24%
Tr1m	1.09%
Tr1w	-18.58%
Tr3m	-38.71%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.04
Earnings Revenue Estimate	111,900,000x
Earnings Revenue Estimate Growth	-1.19x
Operating Income	$-12.3M
Operating margin	-2.87
Price target	$5
Price Target Change	$1,216

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113,055,687%
Float Percent	95.03%
Net Borrowing	10,275,000
Shares Insiders	4.81%
Shares Institutions	68.94%
Shares Out	118,963,696
Shares Qo Q	2.75%
Shares Yo Y	16.57%
Short Float	6.99%
Short Ratio	5.1
Short Shares	6.64

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-33.4M
Average Volume	1,479,544.95x
Bv Per Share	0.35
CAPEX	$-6.7M
Ch10y	-92.5
Ch15y	-95.24
Ch1m	1.09
Ch1w	-18.58
Ch1y	-72.06
Ch3m	-38.71
Ch3y	-89.27
Ch5y	-92.15
Ch6m	-67.52
Change	29.65%
Change From Open	21.02
Close	0.29
Days Gap	7.13
Depreciation Amortization	6,715,000
Dollar Volume	1,559,374.5
Earnings Date	2026-05-06
Earnings Time	amc
EBIT	$-12.3M
EBITDA	$-5.6M
EPS	$-0.39
F Score	2
FCF	$-25.8M
FCF EV Yield	-13.63x
FCF Per Share	$-0.22
Financing CF	-2,492,000
Fiscal Year End	June
Founded	1,990
Goodwill	57,882,000
Income Tax	$2.5M
Investing CF	-14,328,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2025-08-28
Ma150	0.84
Ma150ch	-54.68%
Ma20	0.44
Ma20ch	-12.84%
Net CF	-35,801,000
Next Earnings Date	2026-08-12
Open	0.31
Optionable	Yes
Position In Range	100
Post Close	0.38
Postmarket Change Percent	-6.58
Postmarket Price	$0.36
Ppne	57,900,000
Pre Close	0.29
Price Date	2026-05-08
Relative Volume	2.77x
Revenue	428,571,000x
SBC By Revenue	1.77x
Share Based Comp	7,594,000
Tax By Revenue	0.57x
Tr6m	-67.52%
Us State	Wisconsin
Volume	4,103,617
Z Score	-0.48

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ARAY pay a dividend?

Capital-return profile for this ticker.

Performance

ARAY stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ARAY?

Insider, institutional, and short-interest positioning.

Institutional ownership

+68.9%

Float: +95.0% of shares outstanding

Insider ownership

+4.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ARAY momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.4

Neutral momentum band

Price vs 200-day MA

-62.3%

50/200-day relationship not available

Beta (5Y)

1.43

More volatile than the market

Sharpe ratio

-0.96

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ARAY

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ARAY stock rating?

Accuray Incorporated is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ARAY analysis?

The full report lives at /stocks/ARAY/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ARAY?

The latest report frames ARAY around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ARAY page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.